| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-04-2045 |
| P698 | PubMed publication ID | 15814657 |
| P50 | author | Richard Ellenbogen | Q60055582 |
| P2093 | author name string | A Blank | |
| John R Silber | |||
| Michael S Bobola | |||
| J Russell Geyer | |||
| Ryan D Goff | |||
| P4510 | describes a project that uses | UW479 | Q54992385 |
| Res186 | Q54949778 | ||
| Res196 | Q54949779 | ||
| Res199 | Q54949780 | ||
| Res251 | Q54949781 | ||
| Res253 | Q54949782 | ||
| Res254 | Q54949783 | ||
| Res256 | Q54949784 | ||
| Res259 | Q54949786 | ||
| Res280 | Q54949787 | ||
| Res286 | Q54949788 | ||
| UW228-1 | Q54992373 | ||
| UW228-2 | Q54992374 | ||
| UW228-3 | Q54992375 | ||
| UW467 | Q54992383 | ||
| UW473 | Q54992384 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain tumor | Q233309 |
| cell line | Q21014462 | ||
| P304 | page(s) | 2747-2755 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines | |
| P478 | volume | 11 |
| Q36455403 | A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study |
| Q37120694 | Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells |
| Q34157597 | Apurinic/apyrimidinic endonuclease is inversely associated with response to radiotherapy in pediatric ependymoma |
| Q34971940 | Cerebral blood volume calculated by dynamic susceptibility contrast-enhanced perfusion MR imaging: preliminary correlation study with glioblastoma genetic profiles |
| Q38431462 | Chemoresistance and chemotherapy targeting stem-like cells in malignant glioma. |
| Q35521316 | Chemoresistance of glioblastoma cancer stem cells--much more complex than expected |
| Q39479445 | Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen |
| Q37469921 | Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes |
| Q37660295 | EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma |
| Q47128186 | Effect of O6-methylguanine-DNA methyltransferase methylation in medulloblastoma |
| Q36355916 | Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic response |
| Q36179161 | EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion |
| Q35818728 | Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines |
| Q54412464 | Expression of O⁶-methylguanine-DNA methyltransferase in childhood medulloblastoma. |
| Q39413826 | Glucosylceramide synthase protects glioblastoma cells against autophagic and apoptotic death induced by temozolomide and Paclitaxel. |
| Q35583984 | Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma |
| Q26738711 | In vitro models of medulloblastoma: Choosing the right tool for the job |
| Q35159084 | Kinetics of porphyrin fluorescence accumulation in pediatric brain tumor cells incubated in 5-aminolevulinic acid. |
| Q39736118 | MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib. |
| Q39170565 | MGMT repletion after treatment of glioblastoma cells with temozolomide and O6-benzylguanine implicates NFκB and mutant p53. |
| Q39646080 | MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature |
| Q36387895 | Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours |
| Q28475285 | Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development |
| Q37422646 | New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence. |
| Q36547381 | New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors |
| Q24607903 | O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients |
| Q89497366 | O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy |
| Q35001754 | O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors |
| Q36668242 | Oncolytic viruses and DNA-repair machinery: overcoming chemoresistance of gliomas |
| Q39425287 | PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation. |
| Q28660098 | PGBD5: a neural-specific intron-containing piggyBac transposase domesticated over 500 million years ago and conserved from cephalochordates to humans |
| Q38957473 | Pediatric brain tumor cell lines |
| Q34399645 | RHPS4 G-quadruplex ligand induces anti-proliferative effects in brain tumor cells. |
| Q34419939 | Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumors |
| Q48225985 | Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection. |
| Q37615744 | Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy |
| Q37802798 | Temozolomide for corticotroph pituitary adenomas refractory to standard therapy. |
| Q33374472 | Temozolomide in children with progressive low-grade glioma |
| Q34722864 | Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group |
| Q30442049 | Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas |
| Q28273012 | Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agents |
Search more.